Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Olumiant“
Suchtreffer
Begriffe & Kennungen
Olumiant · 4.8 · Cases of abdominal pain were usually mild, transient, not associated with infectious or inflammatory gastroint
Eintrag öffnenOlumiant · 4.8 · Cases of abdominal pain were usually mild, transient, not associated with infectious or inflammatory gastroint
Eintrag öffnenOlumiant · 4.8 · Creatine phosphokinase (CPK) Baricitinib treatment was associated with dose-dependent increases in CPK. Mean C
Eintrag öffnenOlumiant · 4.8 · Creatine phosphokinase (CPK) Baricitinib treatment was associated with dose-dependent increases in CPK. Mean C
Eintrag öffnenOlumiant · 4.8 · Description of selected adverse reactions
Eintrag öffnenOlumiant · 4.8 · Description of selected adverse reactions
Eintrag öffnenOlumiant · 4.8 · Elevations in LDL cholesterol decreased to pre-treatment levels in response to statin therapy.
Eintrag öffnenOlumiant · 4.8 · Elevations in LDL cholesterol decreased to pre-treatment levels in response to statin therapy.
Eintrag öffnenOlumiant · 4.8 · Frequency estimate: Very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1 000 to < 1/100), rare (≥
Eintrag öffnenOlumiant · 4.8 · Frequency estimate: Very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1 000 to < 1/100), rare (≥
Eintrag öffnenOlumiant · 4.8 · Gastrointestinal disorders In rheumatoid arthritis clinical studies, in treatment-naïve patients, through 52 w
Eintrag öffnenOlumiant · 4.8 · Gastrointestinal disorders In rheumatoid arthritis clinical studies, in treatment-naïve patients, through 52 w
Eintrag öffnenOlumiant · 4.8 · Hepatic transaminase elevations Dose dependent increases in blood ALT and AST activity were reported in studie
Eintrag öffnenOlumiant · 4.8 · Hepatic transaminase elevations Dose dependent increases in blood ALT and AST activity were reported in studie
Eintrag öffnenOlumiant · 4.8 · In clinical trials, there were no confirmed cases of rhabdomyolysis.
Eintrag öffnenOlumiant · 4.8 · In clinical trials, there were no confirmed cases of rhabdomyolysis.
Eintrag öffnenOlumiant · 4.8 · In paediatric patients treated with baricitinib in the placebo-controlled double-blind randomised withdrawal p
Eintrag öffnenOlumiant · 4.8 · In paediatric patients treated with baricitinib in the placebo-controlled double-blind randomised withdrawal p
Eintrag öffnenOlumiant · 4.8 · In patients with rheumatoid arthritis, the combination of baricitinib with potentially hepatotoxic medicinal p
Eintrag öffnenOlumiant · 4.8 · In patients with rheumatoid arthritis, the combination of baricitinib with potentially hepatotoxic medicinal p
Eintrag öffnen